Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Has results × Infusions, Intravenous × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Carboplatin 153 Cisplatin 150 Paclitaxel 149 Docetaxel 114 Cyclophosphamide 114 Dexamethasone 100 Doxorubicin 95 Gemcitabine 89 pembrolizumab 88 Bevacizumab 88 Prednisone 84 Rituximab 81 Fluorouracil 69 Pemetrexed 66 Vincristine 65 Radiotherapy 63 Etoposide 63 Nivolumab 57 Leucovorin 56 Capecitabine 55 Trastuzumab 52 Cytarabine 51 Methotrexate 43 Oxaliplatin 39 atezolizumab 37 Lenalidomide 36 Filgrastim 36 Irinotecan 34 Bortezomib 33 Sorafenib 32

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00399035 2016-12-28

HORIZON II

AstraZeneca

Phase 3 Completed

1,254 enrolled 14 charts

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡